Position in RPRX
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$311,517
+$59,817 QoQ
Shares Held
6,494
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Inscription Capital, LLC holds $5,280,289 across 22 Biotechnology names. RPRX ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALMS |
Alumis Inc.
|
26,213 | $577,472 | |
| 2 | CELC |
Celcuity Inc.
|
4,717 | $538,398 | |
| 3 | TECH |
BIO-TECHNE Corp
|
10,268 | $536,605 | |
| 4 | VNDA |
Vanda Pharmaceuticals Inc.
|
63,878 | $441,396 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
6,494 | $311,517 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
8,595 | $290,768 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
866 | $279,016 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
357 | $275,832 |
All Filings in RPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $311,517 | 6,494 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $251,700 | 6,514 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $229,813 | 6,514 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||